Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 2, 2007, Pages 120-127

  Ewis, Ashraf A ^a,b   El Samman, Essam ^c,d   Ali, Nermin ^c   Kajimoto, Kazuaki ^c   Shinohara, Yasuo ^c   Ishikawa, Mitsuru ^a   Kanayama, Hiro Omi ^c   Baba, Yoshinobu ^a,e  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b Minia University   (Egypt)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d Egyptian National Institute of Oncology   (Egypt)

^e NAGOYA UNIVERSITY   (Japan)

Author keywords

Bilharziasis; Bladder cancer; Complementary deoxyribonucleic acid microarray; Gene expression; Squamous cell carcinoma

Indexed keywords

CADHERIN; GROWTH FACTOR; INTEGRIN; LAMININ;

ARTICLE; BLADDER CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UNINDEXED SEQUENCE; UPREGULATION; UROTHELIUM;

BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33847400477     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.03.006     Document Type: Article

References (33)

1. Warren W., Biggs P.J., el-Baz M., et al. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis 16 (1995) 1181-1189
2. Shokeir A.A. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 93 (2004) 216-220
3. Ghoneim M.A., El-Mekresh M.M., el-Baz M.A., et al. Radical cystectomy for carcinoma of the bladder: Critical evaluation of the results in 1,026 cases. J Urol 158 (1997) 393-399
4. Ghoneim M.A., and Awaad H.K. Results of treatment in carcinoma of the bilharzial bladder. J Urol 123 (1980) 850-852
5. Bahnson R.R. Squamous cell carcinoma of the bladder. J Urol 157 (1997) 2115
6. Thykjaer T., Workman C., Kruhoffer M., et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61 (2001) 2492-2499
7. Sanchez-Carbayo M., Socci N.D., Charytonowicz E., et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 62 (2002) 6973-6980
8. Sanchez-Carbayo M., Socci N., Lozano J.J., et al. Gene identification in bladder cancer progression using cDNA microarrays. Am J Pathol 163 (2003) 505-516
9. Dyrskjot L., Thykjaer T., Kruhoffer M., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33 (2003) 90-96
10. Ramchurren N., Cooper K., and Summerhayes I.C. Molecular events underlying schistosomiasis-related bladder cancer. Int J Cancer 62 (1995) 237-244
11. Koyuncuoglu M., Kargi A., Cingoz S., et al. Investigation of p53, c-cerbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters. Cancer Lett 126 (1998) 143-148
12. In: Sobin L.H., and Wittekind C. (Eds). TNM classification of malignant tumors. 6thed. (2002), Wiley-Liss, New York (NY)
13. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
14. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
15. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
16. Bittner M., Meltzer P., Chen Y., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 (2000) 536-540
17. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 (2001) 10869-10874
18. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
19. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
20. Ramaswamy S., Ross K.N., Lander E.S., et al. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
21. Ami Y., Shimazui T., Akaza H., et al. Gene expression profiles correlate with the morphology and metastasis characteristics of renal cell carcinoma cells. Oncol Rep 13 (2005) 75-80
22. Dyrskjot L., Kruhoffer M., Thykjaer T., et al. Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64 (2004) 4040-4048
23. Orntoft T.F., Thykjaer T., Waldman F.M., et al. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1 (2002) 37-45
24. Swellam M., Abd-Elmaksoud N., Halim M.H., et al. Incidence of Bcl-2 expression in bladder cancer: Relation to schistosomiasis. Clin Biochem 37 (2004) 798-802
25. Badr K.M., Nolen J.D., Derose P.B., et al. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: Frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1). Hum Pathol 35 (2004) 184-189
26. Liebert M., Washington R., Stein J., et al. Expression of the VLA beta 1 integrin family in bladder cancer. Am J Pathol 144 (1994) 1016-1022
27. Pfohler C., Fixemer T., Jung V., et al. In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: Increased basement membrane gene expression in high-grade and metastatic lesions. Prostate 36 (1998) 143-150
28. Stallmach A., von Lampe B., Matthes H., et al. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malignant tumor transformation. Gut 33 (1992) 342-346
29. Yasui W., Sano T., Nishimura K., et al. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer 54 (1993) 49-52
30. Sun W., and Herrera G.A. E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma. Hum Pathol 33 (2002) 996-1000
31. Sato H., Takino T., Okada Y., et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370 (1994) 61-65
32. Suzuki E., Ota T., Tsukuda K., et al. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer 108 (2004) 207-211
33. Bertucci F., Salas S., Eysteries S., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23 (2004) 1377-1391